drugset / Trial / NCT03819218
A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects
NaSingle-groupOpen-labelTreatment
Summary
This is a phase 2, open-label, single-group, multicentre trial in which the investigational product, MC2-01 cream, is investigated in adolescent subjects (age 12 to 16 years, 11 months) with clinically diagnosed extensive psoriasis vulgaris.
Timeline
- Start
- 2018-12-27
- Primary completion
- 2020-12-11
- Completion
- 2020-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcipotriol | Small molecule | 0.005 % | Topical |
| Subject | betamethasone dipropionate | Small molecule | 0.064 % | Topical |